Francesco Florindi

Francesco Florindi has been working at the European Cancer Patient Coalition (ECPC) as Public Affairs Coordinator since 2014.

What are the main day-to-day challenges that the patients you represent face? More than 10 million people in Europe have cancer and there are many day-to-day challenges, primarily related to the way the disease of the patient is managed and how patients cope with the issues related to the disease. What medical technologies are relevant for cancer patients? Cancer patients and therefore ECPC are very well aware surgery and radiotherapy are cornerstones to treating cancer patients and the advancements made in recent years have been crucial in improving survival. The continuous evolution of these technologies is of primary importance for cancer patients, not only to increase outcome, but also to decrease toxicity levels, cut rehabilitation time and overall improve patients’ quality-of-life. What has been most helpful in allowing you to carry on with your everyday life? mHealth plays an important role in providing new solutions to old problems. In particular, patient-reported outcomes have been greatly improved through advances in mHealth, making communications between patients and healthcare professionals easier and faster. The patient-friendly approach to many of these technologies can greatly enhances the cancer patient journey. We appreciate the EU’s and other stakeholders’ increasing focus on eHealth, but we need concrete advances on the implementation side and sustained investments. We do not see mhealth and eHealth as revolutions, but as evolutions: better and faster ways to solve old problems and provide better outcomes for patients. Do you think the patients you represent have enough access to optimal care and that your members know enough about what is available to support you? Absolutely not! Access to essential cancer treatments varies considerably from country-to-country and region-to-region but in general access to optimal care is a major issue. For example, more than 65% of cancer patients in Romania who should have access to some...